Literature DB >> 12120701

The use of multiple sclerosis databases at neurological university hospitals in Germany.

M Pette1, U K Zettl.   

Abstract

The development of easy-to-use, clinically oriented multiple sclerosis (MS) database programs has been started, thus paving the way for MS centers to computerize their patient records and to improve quality management To evaluate the prevalence of such programs at German neurological hospitals, a questionnaire was designed and sent to all clinic directors. With a return of more than 92%, it became evident that MS databases are still being used only by a minority of 22% on a regular basis. We did not recognize the predominance of a single program. A new MS database system that is being presently implemented in Germany is described.

Entities:  

Mesh:

Year:  2002        PMID: 12120701     DOI: 10.1191/1352458502ms805rr

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  4 in total

1.  [MS registry in Germany--design and first results of the pilot phase].

Authors:  P Flachenecker; U K Zettl; U Götze; J Haas; S Schimrigk; W Elias; M Pette; M Eulitz; M Hennig; J Bertram; R Hollweck; A Neiss; M Daumer; D Pitschnau-Michel; P Rieckmann
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 2.  [Multiple sclerosis management system 3D. Moving from documentation towards management of patients].

Authors:  T Schultheiss; R Kempcke; F Kratzsch; M Eulitz; M Pette; H Reichmann; T Ziemssen
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

Review 3.  Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients.

Authors:  Tjalf Ziemssen; Raimar Kempcke; Marco Eulitz; Lars Großmann; Alexander Suhrbier; Katja Thomas; Thorsten Schultheiss
Journal:  J Neural Transm (Vienna)       Date:  2013-06-01       Impact factor: 3.575

Review 4.  The role of information system in multiple sclerosis management.

Authors:  Sima Ajami; Golchehreh Ahmadi; Masoud Etemadifar
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.